Sergio Aguggini

1.6k total citations
34 papers, 1.3k citations indexed

About

Sergio Aguggini is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Sergio Aguggini has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 16 papers in Oncology and 10 papers in Genetics. Recurrent topics in Sergio Aguggini's work include Breast Cancer Treatment Studies (14 papers), Estrogen and related hormone effects (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Sergio Aguggini is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Estrogen and related hormone effects (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Sergio Aguggini collaborates with scholars based in Italy, United Kingdom and Australia. Sergio Aguggini's co-authors include Alberto Bottini, Luigi Dogliotti, Giovanni Allevi, Maria Pia Brizzi, Daniele Generali, Alessandra Bersiga, Alfredo Berruti, Adrian L. Harris, Stephen B. Fox and Manuela Milani and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Sergio Aguggini

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergio Aguggini Italy	17	709	665	470	159	141	34	1.3k
Giovanni Allevi Italy	17	669 0.9×	603 0.9×	437 0.9×	150 0.9×	136 1.0×	36	1.2k
Alessandra Bersiga Italy	16	658 0.9×	641 1.0×	458 1.0×	146 0.9×	124 0.9×	31	1.2k
Rosalía Caballero Spain	14	599 0.8×	639 1.0×	454 1.0×	178 1.1×	157 1.1×	42	1.2k
Yasuyo Ohi Japan	21	474 0.7×	635 1.0×	314 0.7×	123 0.8×	177 1.3×	60	1.2k
Naofumi Kagara Japan	21	739 1.0×	637 1.0×	673 1.4×	102 0.6×	220 1.6×	65	1.6k
Davendra Segara Australia	18	520 0.7×	585 0.9×	660 1.4×	272 1.7×	250 1.8×	27	1.4k
Atsushi Shimomura Japan	21	595 0.8×	513 0.8×	439 0.9×	88 0.6×	213 1.5×	48	1.1k
Hans Kristian Moen Vollan Norway	18	573 0.8×	466 0.7×	705 1.5×	165 1.0×	213 1.5×	25	1.3k
Anita Bane Canada	19	509 0.7×	543 0.8×	440 0.9×	129 0.8×	151 1.1×	41	1.2k
Frédérique Spyratos France	24	788 1.1×	660 1.0×	878 1.9×	280 1.8×	204 1.4×	41	1.7k

Countries citing papers authored by Sergio Aguggini

Since Specialization

Citations

This map shows the geographic impact of Sergio Aguggini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Aguggini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Aguggini more than expected).

Fields of papers citing papers by Sergio Aguggini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Aguggini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Aguggini. The network helps show where Sergio Aguggini may publish in the future.

Co-authorship network of co-authors of Sergio Aguggini

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Aguggini. A scholar is included among the top collaborators of Sergio Aguggini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Aguggini. Sergio Aguggini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schettini, Francesco, Silvana Saracchini, Serena Corsetti, et al.. (2024). Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study. The Breast. 76. 103753–103753. 1 indexed citations

Schettini, Francesco, Maria Valeria De Bonis, Carla Strina, et al.. (2023). Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib. Scientific Reports. 13(1). 11951–11951.

Generali, Daniele, Silvia Paola Corona, Lajos Pusztai, et al.. (2018). Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR. Journal of Cancer Research and Clinical Oncology. 144(3). 601–606. 3 indexed citations

Andreis, Daniele, Giovanni Allevi, Sergio Aguggini, et al.. (2016). Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. The Breast. 29. 55–61. 8 indexed citations

Generali, Daniele, Alfredo Berruti, Laura Zanotti, et al.. (2015). Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1 and Relation to Clinical Response. JNCI Monographs. 2015(51). 64–66. 6 indexed citations

Allevi, Giovanni, Carla Strina, Daniele Andreis, et al.. (2013). Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer. British Journal of Cancer. 108(8). 1587–1592. 46 indexed citations

Generali, Daniele, Stephen B. Fox, Maria Pia Brizzi, et al.. (2010). Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. Breast Cancer Research and Treatment. 123(3). 795–804. 12 indexed citations

Generali, Daniele, Gaynor J. Bates, Maria Pia Brizzi, et al.. (2009). Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients. Clinical Cancer Research. 15(3). 1046–1051. 129 indexed citations

Generali, Daniele, Andrea Dovio, Marco Tampellini, et al.. (2008). Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. British Journal of Cancer. 98(11). 1753–1758. 14 indexed citations

10.

Generali, Daniele, Stephen B. Fox, Maria Pia Brizzi, et al.. (2008). Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer. Clinical Cancer Research. 14(9). 2673–2680. 45 indexed citations

11.

Generali, Daniele, Stephen B. Fox, Alfredo Berruti, et al.. (2007). Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer. Clinical Cancer Research. 13(2). 550–558. 12 indexed citations

12.

Dovio, Andrea, Daniele Generali, Marco Tampellini, et al.. (2007). Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. Osteoporosis International. 19(1). 113–117. 21 indexed citations

13.

Generali, Daniele, Stephen B. Fox, Alfredo Berruti, et al.. (2006). Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocrine Related Cancer. 13(3). 921–930. 66 indexed citations

14.

Berruti, Alfredo, Alberto Bottini, Giovanni Allevi, et al.. (2004). Magnetic Resonance Imaging in Comparison to Clinical Palpation in Assessing the Response of Breast Cancer to Epirubicin Primary Chemotherapy. Breast Cancer Research and Treatment. 85(3). 211–218. 30 indexed citations

15.

Bottini, Alberto, Alfredo Berruti, Maria Pia Brizzi, et al.. (2003). Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. British Journal of Cancer. 89(6). 977–982. 35 indexed citations

16.

Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2002). Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.. PubMed. 8(6). 1816–21. 41 indexed citations

17.

Berruti, Alfredo, Alberto Bottini, Maria Pia Brizzi, et al.. (2001). Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Research and Treatment. 69(2). 143–151. 47 indexed citations

18.

Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2001). Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer. British Journal of Cancer. 85(8). 1106–1112. 68 indexed citations

19.

Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2000). p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.. PubMed. 6(7). 2751–8. 103 indexed citations

20.

Bottini, Alberto, Alfredo Berruti, Marco Tampellini, et al.. (1997). Influence of Neoadjuvant Chemotherapy on Serum Tumor Markers CA 15-3, MCA, CEA, TPS and TPA in Breast Cancer Patients with Operable Disease. Tumor Biology. 18(5). 301–310. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact